0001104659-20-140312.txt : 20201229
0001104659-20-140312.hdr.sgml : 20201229
20201229215334
ACCESSION NUMBER: 0001104659-20-140312
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201229
DATE AS OF CHANGE: 20201229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERMAN DENNIS N
CENTRAL INDEX KEY: 0001273858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 201423921
MAIL ADDRESS:
STREET 1: 9605 SCRANTON RD
STREET 2: STE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
tm2039455d6_form4.xml
FORM 4
X0306
4
2020-12-22
0
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001273858
BERMAN DENNIS N
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA
GA
30339
1
0
0
0
Stock Option (right to buy)
10.00
2020-12-22
4
A
0
6825
0
A
2021-12-22
2030-12-22
Common Stock
6825
6825
D
/s/ Milton H. Werner, attorney-in-fact
2020-12-29